| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002011771A2 Contrast medium consisting of geometrically highly ordered proteins for medical diagnostics |
| 02/14/2002 | WO2002011770A1 Compositions for preventing urinary calculus |
| 02/14/2002 | WO2001064874A3 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/14/2002 | WO1995029669A3 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 02/14/2002 | US20020019992 Transgenic non-human mammals with progressive neurologic disease |
| 02/14/2002 | US20020019442 Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications |
| 02/14/2002 | US20020019340 Polymer stabilized neuropeptides |
| 02/14/2002 | US20020019017 RDiagnosing cancer; monitor human milk duct, inject washing fluid, recover fluid from duct, evaluate particles recovered from wash |
| 02/14/2002 | US20020018779 Non-anaphylactic forms of allergens and their use |
| 02/14/2002 | US20020018728 Peristaltic compressors suitable for relaxation-free compression of polarized gas |
| 02/14/2002 | CA2418936A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | CA2417769A1 Drug metabolizing enzymes |
| 02/14/2002 | CA2417676A1 Sequences for integrin alpha-8 |
| 02/14/2002 | CA2416531A1 Compositions for preventing urinary calculus |
| 02/13/2002 | EP1179189A2 Process |
| 02/13/2002 | EP1178975A1 Gadolinium complex tetramides and use in medical imaging |
| 02/13/2002 | EP1178838A2 Macromolecular carrier for drug and diagnostic agent delivery |
| 02/13/2002 | EP1178837A2 Method for enhancing contrast produced by mri |
| 02/13/2002 | EP1178830A2 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 02/13/2002 | EP1178814A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/12/2002 | US6347241 Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it |
| 02/12/2002 | US6346229 Methods for imaging pulmonary and cardiac vasculature and evaluating blood flow using dissolved polarized 129Xe |
| 02/07/2002 | WO2002010192A2 Somatostatin analogues |
| 02/07/2002 | WO2002010173A1 Dihydroporphyrin derivatives and their uses |
| 02/07/2002 | WO2002010120A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/07/2002 | WO2002010119A1 Preparation of sterile crystals of 5-aminolevulinic acid utilized for medical diagnostic and therapeutic purposes, and a device for facilitating this diagnostic process |
| 02/07/2002 | WO2002009721A1 Method of increasing sensitivity of mammography |
| 02/07/2002 | WO2001085906A3 Catalytically active peptides |
| 02/07/2002 | WO2001032210A3 Compositions for treating atheroma and neoplastic tissue |
| 02/07/2002 | US20020016978 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
| 02/07/2002 | US20020016284 Detecting or measuring the amount of oxidative stress or damage in a subject suspected of having Alzheimer's disease; screening, diagnosis, therapy |
| 02/07/2002 | US20020015704 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 02/07/2002 | US20020015680 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis |
| 02/07/2002 | CA2417326A1 Method of increasing sensitivity of mammography |
| 02/07/2002 | CA2416523A1 Dihydroporphyrin derivatives and their uses |
| 02/07/2002 | CA2416307A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/06/2002 | EP1177795A2 Use of ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 02/06/2002 | EP1176987A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |
| 02/06/2002 | EP0938330B1 Use of lh-rh antagonists as diagnostic agent |
| 02/06/2002 | CN1078815C Microparticle agent made of biological degradable copolymer |
| 02/05/2002 | US6344182 Preparation of diagnostic agents by spray drying |
| 02/05/2002 | US6344180 Beta-cell stimulatory tests to test beta-cell function; provides information about insulin secretory capacity, is easy and reproducible and has insignificant side effects. |
| 02/05/2002 | US6343602 Method of and a device for dry application of substances on inhalable pulverulent carrier substances |
| 02/05/2002 | CA2127284C Protein- and peptide-metal ion pharmaceutical applications |
| 02/05/2002 | CA2110290C Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 01/31/2002 | WO2002008405A1 Isocitrate dehydrogenases, their genes, and use in antioxidative system suppressive of ros-mediated diseases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002007846A1 Extended organic cobalt and nickel magnetic complexes |
| 01/31/2002 | WO2002007779A1 Long wavelength long lifetime luminophores |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007693A1 Improved diagnostic method for detecting dysplastic epithelial tissue |
| 01/31/2002 | WO2001085214A8 Radio-opaque polymeric compositions |
| 01/31/2002 | WO2001062784A3 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/31/2002 | WO2001060416A3 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 01/31/2002 | US20020013531 Sentinel lymph node detection method and system therefor |
| 01/31/2002 | US20020013266 Polymer stabilized neuropeptides |
| 01/31/2002 | US20020013263 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/31/2002 | US20020013259 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 01/31/2002 | US20020012630 Producing wound in skin or another external body surface of an animal; permitting wound to heal in absence of test compound, or treating wound with a test compound; comparing wound healing, identifying a compound improves healing |
| 01/31/2002 | CA2797652A1 Multi-component biological transport systems |
| 01/31/2002 | CA2416733A1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2416526A1 Extended organic cobalt and nickel magnetic complexes |
| 01/30/2002 | EP1175392A1 Contrast media |
| 01/30/2002 | EP1175227A1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 01/30/2002 | EP0871896B1 A method of determining oxygen concentration in a sample |
| 01/30/2002 | EP0696919B1 Diagnosis and treatment of erectile dysfunction |
| 01/30/2002 | EP0670041B1 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
| 01/30/2002 | CN1333695A Blood pool agents for nulcear magnetic resonance diagnostics |
| 01/30/2002 | CN1078480C Somatostatin binding peptide-metal chelate conjugates |
| 01/30/2002 | CN1078479C Preparation for disgnostic of the metabolic syndrome and diseases includingthe syndrome |
| 01/29/2002 | US6343225 Implantable glucose sensor |
| 01/29/2002 | US6342598 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 01/29/2002 | US6342597 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents |
| 01/29/2002 | US6342588 Conjugating biotin-tyramine label to proteins, peptides, or ligands comprising specific binding pair by use of hydrogen peroxidase enzyme; gene expression from modified nucleic acid; genetic engineering |
| 01/29/2002 | US6342480 Tumor-activated prodrug compounds and treatment |
| 01/29/2002 | CA2207624C Selective and non-invasive visualization or treatment of vasculature |
| 01/24/2002 | WO2002006516A1 Methods of modulating angiogenesis |
| 01/24/2002 | WO2002006287A2 Macrocyclic mri contrast agents |
| 01/24/2002 | WO2002005858A2 Fluorescent agents for real-time measurement of organ function |
| 01/24/2002 | WO2002005803A1 Functionalized active-nucleus complex sensor |
| 01/24/2002 | WO2002005634A2 Transgenic animal and methods |
| 01/24/2002 | WO2001053324A3 Novel haptotactic peptides |
| 01/24/2002 | WO2001052906A3 Magnetic resonance imaging using contrast agents prodrugs bioactivated by enzymatic cleavage |
| 01/24/2002 | WO2001036005A3 Targeted delivery of therapeutic and diagnostic moieties |
| 01/24/2002 | US20020010415 System and method for assessing the performance of a pharmaceutical agent delivery system |
| 01/24/2002 | US20020010397 Method and apparatus for administration of contrast agents for use in magnetic resonance arteriography |
| 01/24/2002 | US20020010368 Preparation of iodixanol |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009491 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 01/24/2002 | US20020009416 Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system |
| 01/24/2002 | CA2418206A1 Fluorescent agents for real-time measurement of organ function |
| 01/23/2002 | EP1174153A2 Gas emulsions stabilized with fluorinated ethers having low ostwald coefficients |
| 01/23/2002 | EP1173766A1 A tenascin-c isoform as a marker for neoplasias |
| 01/23/2002 | EP1173757A1 Diagnosis of human kidney diseases |
| 01/23/2002 | EP1173600A2 Cationic peg-lipids and methods of use |
| 01/23/2002 | EP1173561A2 Non-invasive method for detecting target rna |